Pituitary volume in first-episode schizophrenia

Psychiatry Research - Neuroimaging

Volumn 203, Issue 1, 2012, Pages 100-102

  Gruner, Patricia ^a,b   Christian, Christopher ^c   Robinson, Delbert G ^a,b,d   Sevy, Serge ^b   Gunduz Bruce, Handan ^e,f   Napolitano, Barbara ^a,b,d   Bilder, Robert M ^g,h   Szeszko, Philip R ^a,b,d  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotic treatment; Magnetic resonance imaging; Psychosis

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; OLANZAPINE; PERPHENAZINE; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DSM-IV; FEMALE; FOLLOW UP; HUMAN; HYPOPHYSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PITUITARY GLAND; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEX FACTORS;

EID: 84866287371     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.09.017     Document Type: Article

References (26)

1. Amsterdam J.D., Maislin G., Gold P., Winokur A. The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness. Psychoneuroendocrinology 1989, 14:43-62.
2. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Kubera M., Leskiewicz M., Otczyk M., Lason W. Antipsychotic drugs inhibit the human corticotrophin-releasing-hormone gene promoter activity in neuro-2A cells - an involvement of protein kinases. Neuropsychopharmacology 2006, 31:853-865.
3. De Groot J., Harris G.W. Hypothalamic control of the anterior pituitary gland and blood lymphocytes. The Journal of Physiology 1950, III:335-346.
4. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. (SCID-I/P, Version 2.0, 8/98 Revision). Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition 1998, Biometrics Research Department, New York State Psychiatric Institute.
5. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. (SCID-I/NP, Version 2.0, 2/01 Revision). Structured Clinical Interview for DSM-IV Axis I Disorders - Non-patient Edition 2001, Biometrics Research Department, New York State Psychiatric Institute.
6. Gruen P.H., Sachar E.J., Langer G., Altman N., Leifer M., Frantz A., Halpern F.S. Prolactin responses to neuroleptics in normal schizophrenic subjects. Archives of General Psychiatry 1978, 35:108-116.
7. Gustafsson P.E., Gustafsson P.A., Ivarsson T., Nelson N. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology 2008, 57:14-21.
8. Lehman A.F., Kreyenbuhl J., Buchanan R.W., Dickerson F.B., Dixon L.B., Goldberg R., Green-Paden L.D., Tenhula W.N., Boerescu D., Tek C., Sandson N., Steinwachs D.M. The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2003. Schizophrenia Bulletin 2004, 30:193-217.
9. MacMaster F.P., El-Sheikh R., Upadhyaya A.R., Nutche J., Rosenberg D.R., Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naïve first episode schizophrenia: a pilot study. Schizophrenia Research 2007, 92:207-210.
10. MacMaster F.P., Keshavan M., Mirza Y., Carrey N., Upadhyaya A.R., El-Sheikh R., Buhagiar C.J., Taormina S.P., Boyd C., Lynch M., Rose M., Ivey J., Moore G.J., Rosenberg D.R. Development and sexual dimorphism of the pituitary gland. Life Sciences 2007, 80:940-944.
11. MEDx Sensor Systems 1998, Virginia.
12. Meltzer H.Y., Fang V.S. The effect of neuroleptics on serum prolactin in schizophrenic patients. Archives of General Psychiatry 1976, 33:279-286.
13. Muck-Seler D., Pivac N., Jakovljevic M., Brzovic Z. Platelet secretion, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biological Psychiatry 1999, 45:1433-1439.
14. Nicolo J., Berger G., Garner B.A., Velakoulis D., Markulev C., Kerr M., McGorry P.D., Proffitt T., McConchie M., Pantelis C., Wood S.J. The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study. Schizophrenia Research 2010, 116(1):49-54.
15. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., Brewer W., Smith D.J., Dazzan P., Yung A.R., Zervas I.M., Christodoulou G.N., Murray R., McGorry P.D., Pantelis C. Pituitary volume in psychosis. British Journal of Psychiatry: The Journal of Mental Science 2004, 185:5-10.
16. Pariante C.M., Dazzan P., Danese A., Morgan K.D., Brudaglio F., Morgan C., Fearon P., Orr K., Hutchinson G., Pantelis C., Velakoulis D., Jones P.B., Leff J., Murray R.M. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 2005, 30:1923-1931.
17. Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. The American Journal of Psychiatry 2003, 160:284-289.
18. Ryan M.C., Sharifi N., Condren R., Thakore J.H. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia. Psychoneuroendocrinology 2004, 29:1065-1070.
19. Sam S., Frohman L.A. Normal physiology of hypothalamic pituitary regulation. Endocrinology and Metabolism Clinics of North America 2008, 37:1-22.
20. Takahashi T., Suzuki M., Velakoulis D., Lorenzetti V., Soulsby B., Zhou S.Y., Nakamura K., Seto H., Kurachi M., Pantelis C. Increased pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research 2009, 108:114-121.
21. Takano K., Utsunomiya H., Ono H., Ohfu M., Okazaki M. Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. American Journal of Neuroradiology 1999, 20:312-315.
22. Tournikioti K., Tansella M., Perlini C., Rambaldelli G., Cerini R., Versace A., Andreone N., Dusi N., Balestrieri M., Malago R., Gasparini A., Brambilla P. Normal pituitary volumes in chronic schizophrenia. Psychiatry Research: Neuroimaging 2007, 154:41-48.
23. Upadhyaya A.R., El-Sheikh R., MacMaster F.P., Diwardkar V.A., Keshavan M.S. Pituitary volume in neuroleptic-naïve schizophrenia: a structural MRI study. Schizophrenia Research 2007, 90(1-3):266-273.
24. Walker E.F., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychological Review 1997, 104:667-685.
25. Walsh P., Spelman L., Sharifi N., Thakore J.H. Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release. Psychoneuroendocrinology 2005, 30:431-437.
26. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. The Journal of Clinical Psychiatry 2003, 64:663-667.